The Medtronic Registry for Epilepsy (MORE) aims to assess ANT DBS therapy’s safety and longer-term effectiveness in routine clinical practice.
Epilepsy Awareness Night with the Chicago White Sox, our mental health webinar, and more in this Update.
Early identification of children who will develop epilepsy after a CFS is essential to future management and counseling for parents/caregivers
The prevalence of seizures roughly doubles between the ages of 50 and 80 years. More than 95% of patients with epilepsy are treated with ASMs as they are effective at preventing recurrent seizures; however, older adults may be vulnerable to the side effects of ASMs.
CBD
Up to 1 in 4 people with hard-to-treat epilepsy, including those with Dravet syndrome, were found to stop taking Epidiolex (cannabidiol) shortly after starting treatment, primarily due to side effects or a lack of efficacy, according to a real-world study.
A new study finds that some infants who die of SIDS have abnormalities in a particular brain receptor that may be involved in helping them gasp for air.
Findings suggest that diagnostic delays are common for this rare form of the disease, so researchers urge clinicians to consider it as a potential diagnosis for patients who develop vision problems in childhood and seizures in adolescence or adulthood.
SUDEP
Effective long-term medical treatment with cenobamate may reduce excess mortality associated with epilepsy.
CBD
Future research needs to investigate the therapeutic effects of CBD and AEs in the presence of various dosages of other antiepileptic dugs in order to achieve a safe and effective dose for treatment-resistant patients with epilepsy.
